VISFATIN AS A PHYSIOLOGICAL MODULATOR AND ITS BIOCHEMICAL ROLE IN THE PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS: A CURRENT PERSPECTIVE

Résumé fourni par la source

Visfatin is a multifaceted novel adipokine which was initially identified as Pre-B cell Colony Enhancing Factor (PBEF).It functions as a pro-inflammatory cytokine and a key enzyme in the Nicotinamide Adenine Dinucleotide (NAD+) salvage pathway and hence it’s also known as Nicotinamide phosphoribosyltransferase(NAMPT). It operates both intracellularly (iNAMPT) to regulate NAD+ biosynthesis where its inhibition yields anti-inflammatory and anti cancer effects and extracellularly (eNAMPT) in the circulation .Recent studies have highlighted the connecting link between PBEF and the pathophysiology of Type 2 Diabetes Mellitus (T2DM). This review explores visfatin's diverse roles as iNAMPT, eNAMPT, an adipocytokine, and a metabolic regulator, while focusing on its mechanisms in type 2 diabetes mellitus considering its increasing global prevalence. Additionally, future implications as a potential therapeutic target for the prevention, treatment and management of T2DM will also be discussed.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.